WICKENDEN; Alan
Patent Applications and Registrations
Patent applications and USPTO patent grants for WICKENDEN; Alan.The latest application filed is for "protoxin-ii variants and methods of use thereof".
- WICKENDEN; Alan - San Diego CA
- Wickenden; Alan - Cary NC
| Patent | Date |
|---|---|
| Protoxin-ii Variants And Methods Of Use Thereof App 20220054590 - FLINSPACH; Mack ; et al. | 2022-02-24 |
| Protoxin-ii Variants And Methods Of Use App 20210363204 - FLINSPACH; Mack ; et al. | 2021-11-25 |
| Protoxin-II variants and methods of use Grant 11,083,776 - Flinspach , et al. August 10, 2 | 2021-08-10 |
| Protoxin-II variants and methods of use Grant 10,995,125 - Flinspach , et al. May 4, 2 | 2021-05-04 |
| Protoxin-II variants and methods of use Grant 10,975,129 - Flinspach , et al. April 13, 2 | 2021-04-13 |
| Protoxin-ii Variants And Methods Of Use App 20200054712 - FLINSPACH; Mack ; et al. | 2020-02-20 |
| Protoxin-ii Variants And Methods Of Use App 20200048316 - Flinspach; Mack ; et al. | 2020-02-13 |
| Protoxin-II variants and methods of use Grant 10,463,714 - Flinspach , et al. No | 2019-11-05 |
| Huwentoxin-IV variants and methods of use Grant 10,414,808 - Eckert , et al. Sept | 2019-09-17 |
| Kv1.3 Antagonists and Methods of Use App 20190062383 - Chi; Ellen ; et al. | 2019-02-28 |
| Kv1.3 antagonists and methods of use Grant 10,179,808 - Chi , et al. Ja | 2019-01-15 |
| Protoxin-ii Variants And Methods Of Use App 20170334959 - FLINSPACH; Mack ; et al. | 2017-11-23 |
| Protoxin-II variants and methods of use Grant 9,624,280 - Flinspach , et al. April 18, 2 | 2017-04-18 |
| Protoxin-ii Variants And Methods Of Use App 20160287666 - Flinspach; Mack ; et al. | 2016-10-06 |
| Protoxin-ii Variants And Methods Of Use App 20160257726 - FLINSPACH; Mack ; et al. | 2016-09-08 |
| Sodium Channel Sensitive Conopeptides And Analogs, Including Compositions And Methods Thereof App 20150322120 - Imperial; Julita ; et al. | 2015-11-12 |
| Huwentoxin-IV variants and methods of use Grant 9,102,751 - Flinspach , et al. August 11, 2 | 2015-08-11 |
| Protoxin -ii Variants And Methods Of Use App 20150099705 - FLINSPACH; Mack ; et al. | 2015-04-09 |
| Huwentoxin-iv Variants And Methods Of Use App 20150087596 - Eckert; William ; et al. | 2015-03-26 |
| Kv1.3 Antagonists and Methods of Use App 20140255401 - Chi; Ellen ; et al. | 2014-09-11 |
| Huwentoxin-iv Variants And Methods Of Use App 20130310324 - Flinspach; Mack ; et al. | 2013-11-21 |
| Antibodies to human Elk, a voltage-gated potassium channel subunit Grant 7,355,009 - Jegla , et al. April 8, 2 | 2008-04-08 |
| BK beta subunits of Slo family potassium channels Grant 7,351,553 - Jegla , et al. April 1, 2 | 2008-04-01 |
| BK beta subunits of Slo family potassium channels Grant 6,994,968 - Jegla , et al. February 7, 2 | 2006-02-07 |
| BK beta subunits of Slo family potassium channels App 20060004187 - Jegla; Timothy James ; et al. | 2006-01-05 |
| Human Elk, a voltage-gated potassium channel subunit App 20050227250 - Jegla, Timothy J. ; et al. | 2005-10-13 |
| Human Elk, a voltage-gated potassium channel subunit Grant 6,833,440 - Jegla , et al. December 21, 2 | 2004-12-21 |
| Human Elk, a voltage-gated potassium channel subunit App 20030077731 - Jegla, Timothy J. ; et al. | 2003-04-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 